Clinical Trials in Cleveland

Showing 2301-2320 of 9,497 trials

A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

NCT04641962

The purpose of this study was to evaluate the dose response of Bocidelpar on functional improvement relative to placebo, safety, and tolerability in participants with Primary Mitochondrial Myopathy.

Primary Mitochondrial Myopathy

Astellas Pharma Inc34 participantsStarted May 2021

La Jolla, California, United States • Stanford, California, United States • Aurora, Colorado, United States +8 more locations

TERMINATEDNA< 1 mile

STEM-PD Open Label Extension (OLE)

NCT04799418

This study seeks to establish the safety and efficacy of extended twice daily time-varying caloric vestibular stimulation treatments for treating symptoms associated with Parkinson's disease. Only participants who completed the STEM-PD randomized controlled trial portion (NCT04797611) are eligible to participate in the open label extension portion.

Parkinson DiseaseParkinson's Disease and Parkinsonism

Scion NeuroStim148 participantsStarted Sep 2022

Scottsdale, Arizona, United States • Los Angeles, California, United States • Boca Raton, Florida, United States +12 more locations

A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

STEM-PD Open Label Extension (OLE)

Find Trials by Condition in Cleveland

Comparing Different Types of Physical Therapy for Treating People With a Meniscal Tear and Osteoarthritis

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

Vaginal Ecosystem and Network in the United States Study

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Cough Reduction in IPF With Nalbuphine ER

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Gluten Technology and Education for Celiac Health